Trademark Search  /  OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

● Live · Registered

U.S. federal trademark · Serial No. 97342302 · Reg. No. 7130293

Mark
OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)
Status
Registered
Serial Number
97342302
Registration No.
7130293
Filing Date
April 1, 2022
Registration Date
August 8, 2023
Class(es)
Class 005

Owners

Bristol-Myers Squibb Company
03 · Princeton, NJ, US
Bristol-Myers Squibb Company
03 · Princeton, NJ, US
Bristol-Myers Squibb Company
03 · New York, NY, US

Goods & Services

Pharmaceutical preparations for human use comprising monoclonal antibodies for the treatment and prevention of cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.